| Sumit Agarwal, DO | |
|
537 Us Highway 22 E Fl 3, Whitehouse Station, NJ 08889-3696 | |
| (908) 237-4155 | |
| (908) 534-6634 |
| Full Name | Sumit Agarwal |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 10 Years |
| Location | 537 Us Highway 22 E Fl 3, Whitehouse Station, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306262035 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MB10095900 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Visiting Nurse Assoc Of Northern New Jersey, Inc | Morristown, NJ | Home health agency |
| Hunterdon Medical Center | Flemington, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hunterdon Primary Care Pc | 4486951183 | 54 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced the issuance of United States patent 7,655,002. This patent addresses methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.
Patients receiving Botox Cosmetic treatments can reduce wrinkles with half as many sessions after 20 months, according to research conducted at Oregon Health & Science University's Casey Eye Institute.
Patients with vascular malformations, which include blood vessel, artery and lymph vessel abnormalities, appear to have more pain and mental health distress than the general U.S. population and that can contribute to poor health-related quality of life.
› Verified 1 days ago
| Entity Name | Apogee Medical Group Of New Jersey Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104873629 PECOS PAC ID: 8224086103 Enrollment ID: O20050107000014 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced the issuance of United States patent 7,655,002. This patent addresses methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.
Patients receiving Botox Cosmetic treatments can reduce wrinkles with half as many sessions after 20 months, according to research conducted at Oregon Health & Science University's Casey Eye Institute.
Patients with vascular malformations, which include blood vessel, artery and lymph vessel abnormalities, appear to have more pain and mental health distress than the general U.S. population and that can contribute to poor health-related quality of life.
› Verified 1 days ago
| Entity Name | Hunterdon Primary Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225408883 PECOS PAC ID: 4486951183 Enrollment ID: O20160323002029 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced the issuance of United States patent 7,655,002. This patent addresses methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.
Patients receiving Botox Cosmetic treatments can reduce wrinkles with half as many sessions after 20 months, according to research conducted at Oregon Health & Science University's Casey Eye Institute.
Patients with vascular malformations, which include blood vessel, artery and lymph vessel abnormalities, appear to have more pain and mental health distress than the general U.S. population and that can contribute to poor health-related quality of life.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sumit Agarwal, DO 537 Us Highway 22 E Fl 3, Whitehouse Station, NJ 08889-3696 Ph: (908) 237-4155 | Sumit Agarwal, DO 537 Us Highway 22 E Fl 3, Whitehouse Station, NJ 08889-3696 Ph: (908) 237-4155 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced the issuance of United States patent 7,655,002. This patent addresses methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.
Patients receiving Botox Cosmetic treatments can reduce wrinkles with half as many sessions after 20 months, according to research conducted at Oregon Health & Science University's Casey Eye Institute.
Patients with vascular malformations, which include blood vessel, artery and lymph vessel abnormalities, appear to have more pain and mental health distress than the general U.S. population and that can contribute to poor health-related quality of life.
› Verified 1 days ago
Dr. Christina Yu-yee Chan, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Merck Dr, Ws 2d-19, Whitehouse Station, NJ 08889 Phone: 908-423-6048 | |
Mitra Abessi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 537 Us Highway 22 E Fl 3, Whitehouse Station, NJ 08889 Phone: 908-237-4155 Fax: 908-534-6634 | |
Dr. Robert Falcone, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Merck Dr, Ws 1af-35, Whitehouse Station, NJ 08889 Phone: 908-423-4115 Fax: 908-534-3234 | |
Dr. Robert James Cody, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Merck Dr, Whitehouse Station, NJ 08889 Phone: 908-391-8284 | |
Dr. Stephen Ocken, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 Van Cleef Dr, Whitehouse Station, NJ 08889 Phone: 908-400-9805 Fax: 908-923-4092 |